MedTrace Logo

Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes

NCT03781232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2019-12-04

No results posted yet for this study

Summary

The study was established to collect data and reference measurements in order to establish calibration models for the Prototype 0.3

Conditions

  • Diabete Mellitus
  • Medical Device

Interventions

DEVICE

Prototype 0.3

Prototype 0.3 is a non-invasive glucose monitoring device using Raman spectroscopy

Sponsors & Collaborators

  • RSP Systems A/S

    lead INDUSTRY

Principal Investigators

  • Guido Freckmann, Dr. · Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-22
Primary Completion
2019-08-05
Completion
2019-08-05

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03781232 on ClinicalTrials.gov